In 2015, Carter and colleagues first reported that serum lncRNA GAS5 decreases in patients with type 2 diabetes; the results indicated that individuals with absolute GAS5 < 10 ng/μl have almost twelve times higher odds of having diabetes. The gene discussed is GAS5; the disease is type 2 diabetes mellitus.